Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: May 2011
-
By Kevin E. Noonan — The Federal Circuit delivered its en banc opinion on inequitable conduct today in Therasense, Inc. v. Becton, Dickinson & Co. In an opinion written by Chief Judge Rader and joined by Circuit Judges Newman, Lourie, Linn, Moore, and Reyna, and by Judge O'Malley in part, the Court issued clear standards…
-
By Kevin E. Noonan — Under the biologics pathway provisions of the Patient Protection and Affordable Care Act (P.L. 111-148), § 351(k) of the Public Health Service Act, codified at 42 U.S.C. § 262(k)), the FDA is given the authority to develop procedures for approving biosimilar applications. Recognizing the complexities of the issues involved, Congress…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Alza Corp. et al. v. Impax Laboratories, Inc. et al.1:11-cv-00395; filed May 5, 2011 in the District Court of Delaware • Plaintiffs: Alza Corp.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.• Defendants: Impax Laboratories, Inc.; Teva Pharmaceuticals USA, Inc.;…
-
By Donald Zuhn — Earlier this month, the Battelle Memorial Institute announced the issuance of a report concerning the economic impact of the Human Genome Project. In the report, the research group indicated that the return on the $3.8 billion the U.S. government invested in the project between 1988 and 2003 totaled $796 billion. The…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Abbott Products Inc. et al. v. Teva Pharamceuticals USA, Inc.1:11-cv-00384; filed April 29, 2011 in the District Court of Delaware • Plainitffs: Abbott Products Inc.; Unimed Pharmaceuticals LLC; Besins Healthcare Inc.• Defendant: Teva Pharmaceuticals USA,…
-
May 23-25, 2011 – 6th International Judges Conference on Intellectual Property Law (Intellectual Property Owners Association) – Brussels, Belgium June 2, 2011 – EPO Opposition & Appeals — The Case Law (Patent Resources Group and Management Forum) – Chicago, IL June 3, 2011 – European Patents — The Case Law (Patent Resources Group and Management…
-
The American Intellectual Property Law Association (AIPLA) will be holding a multi-session seminar, entitled "Chemical Patent Practice Road Show: Prosecution and Litigation Strategies," on June 23, 2011 in Chicago, IL. The seminar, which covers advanced issues relating to chemical patent prosecution and litigation, features speakers from the U.S. Patent and Trademark Office, chemical and pharmaceutical…
-
The Chisum Patent Academy will offer its third annual Intensive Patent Law Seminar on July 25-27, 2011 in Seattle, WA. The seminar, which is conducted in a roundtable, interactive style, targets first principles as well as the latest patent law developments from the Federal Circuit and U.S. Supreme Court. The syllabus for the 2009 and…
-
Intellectual Asset Management (IAM) magazine will be hosting its 4th annual IP Business Congress on June 19-20, 2011 in San Francisco, CA. The IP Business Congress brings together thought leaders from the worlds of IP business and finance to discuss issues that center on the creation and management of IP value. Among the plenary and…
-
By James DeGiulio — Cephalon's Amrix Patents Infringed But Invalid in Suit against Mylan and Barr Two of Cephalon's patents covering the muscle relaxant Amrix drug were found to be infringed by Mylan and Barr, but those same patents were also found to be invalid for obviousness. Cephalon originally brought six cases against several generic…
Patent Docs 